XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurement (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Liabilities
The table below summarizes the fair values of certain liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and their designations among the three fair value measurement categories:
March 31, 2024
December 31, 2023
Level 1Level 2Level 3Level 1Level 2Level 3
Liabilities
  Warrants
$— $49 $24,512 $— $55 $27,406 
  Embedded derivatives
$— $— $3,889 $— $— $4,423 
Schedule of Assumptions used to Determine Fair Value of Warrants and Embedded Derivative Liabilities
The IPO warrants are classified as Level 2 financial instruments in the table above. They are valued on the basis of the quoted price of the Company’s public warrants, adjusted for insignificant difference between the public warrants and the private placement warrants.
The April 2023 warrants, May 2023 warrants and December 2023 warrants are classified as Level 3 financial instruments in the table above. The Company estimated the fair value of these warrants using the Black-Scholes model at inception and on subsequent valuation dates. This model incorporates inputs such as the stock price of the Company, risk-free interest rate, volatility and time to expiration. The volatility involves unobservable inputs classified as Level 3 of the fair value hierarchy.
The inputs used to determine the fair value of the April 2023 warrants, May 2023 warrants and the December 2023 warrants are as follows:
April 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.54 years4.79 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
May 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.29 years4.54 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
December 2023 warrants
March 31, 2024
December 31, 2023
Time to expiration4.71 years4.96 years
Common stock price$1.03 $1.09 
Risk-free interest rate4.2 %3.8 %
Volatility70.0 %70.0 %
The inputs used to determine the fair value of the embedded derivative liabilities are as follows:
2021 Convertible Note Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield— %— %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
AFG Convertible Notes Payable
March 31, 2024
December 31, 2023
Term2.25 years2.5 years
Dividend yield— %— %
Risk-free interest rate4.5 %4.1 %
Volatility70.0 %70.0 %
Effective debt yield40.0 %40.0 %
Schedule of Liabilities Measured at Fair Value The following table summarizes the changes in the fair value of liabilities that are included within the Company’s accompanying Unaudited Condensed Consolidated Balance Sheets and are designated as Level 3:
Three Months Ended March 31,

2024
2023
Embedded derivatives
Balance at beginning of the period$4,423 $1,945 
Additions— 14,799 
Change in fair value of derivatives - related parties1
(534)4,511 
Balance at end of the period$3,889 $21,255 
Warrants
Balance at beginning of the period$27,406 $— 
Additions— — 
Change in fair value of warrants
(2,894)— 
Balance at end of the period$24,512 $— 
1 Includes loss on debt extinguishment from Yorkville Promissory Note Conversions for the three months ended March 31, 2023.
Schedule of Estimated Fair Value of Financial Instruments Not Carried at Fair Value
The estimated fair value of financial instruments not carried at fair value in the Unaudited Condensed Consolidated Balance Sheets was as follows:
Level in Fair Value Hierarchy
March 31, 2024
December 31, 2023
Carrying ValueFair ValueCarrying ValueFair Value
Notes receivable3$827 $721 $863 $719 
2021 Convertible Note*
396,033 63,034 94,386 57,998 
Senior Secured Term Loan 386,756 64,117 85,624 61,360 
AFG Convertible Notes*317,917 19,076 18,139 18,352 
Equipment financing facility34,924 4,261 5,710 4,826 
  Total$206,457 $151,209 $204,722 $143,255 
*Includes the embedded derivative liabilities.